Resveratrol, an activator of the protein deacetylase SIRT1 and an antioxidant, decreases muscular and cardiac oxidative damage and improves pathophysiological conditions in animal models of muscular dystrophy (MD). This evidence concerns the gene SIRT1 and Menkes disease.